Abstract

Described herein is a method for differentially lysing a liquid sample or target material using an Augmented Oxidizing Agent (AO A), which includes a quantity of Electronically Modified Oxygen Derivatives (EMODs). The method reduces or eliminates total dissolved solids (TDS), total suspended solids (TSS), microbial concentration, biofilms and other content in the liquid target material known or suspected to contain animal fluids, blood and blood cells and suspected or known to contain eukaryotic cells, microbial cells, bacteria, viruses, spores, fungi, prions, organic matter, minerals, proteins or associated structures. The TDS and TSS can be lowered or eliminated as desired. This action is directly proportional to the quantity of EMODs in the AOS applied to the liquid target material.

IPC Classes  ?

• B01D 21/00 - Separation of suspended solid particles from liquids by sedimentation
• B01D 21/01 - Separation of suspended solid particles from liquids by sedimentation using flocculating agents
• B01D 21/06 - Settling tanks with moving scrapers with rotating scrapers

Abstract

Described herein is a method for differentially lysing a liquid sample or target material using an Augmented Oxidizing Agent (AO A), which includes a quantity of Electronically Modified Oxygen Derivatives (EMODs). The method reduces or eliminates total dissolved solids (TDS), total suspended solids (TSS), microbial concentration, biofilms and other content in the liquid target material known or suspected to contain animal fluids, blood and blood cells and suspected or known to contain eukaryotic cells, microbial cells, bacteria, viruses, spores, fungi, prions, organic matter, minerals, proteins or associated structures. The TDS and TSS can be lowered or eliminated as desired. This action is directly proportional to the quantity of EMODs in the AOS applied to the liquid target material.

IPC Classes  ?

• B01D 21/00 - Separation of suspended solid particles from liquids by sedimentation
• B01D 21/01 - Separation of suspended solid particles from liquids by sedimentation using flocculating agents
• B01D 21/06 - Settling tanks with moving scrapers with rotating scrapers

Abstract

Described herein are various methods, systems, and apparatus for reducing and eliminating, microbes, minerals, chemicals and biofilms from contaminated substances. A combination of oxidizing agents and radiation of certain wavelengths forming a synergistic reaction. The synergistic reaction generates EMODs, which are effective in reducing microbial count, unwanted mineral or chemical concentrations and eliminating or blocking biofilm formation, particularly in anaerobic environments. The synergistic reaction produces long lasting EMODs thereby creating a residual effect. This synergistic reaction has a relationship to EMOD creation and has a detrimental effect on microbial contamination (MC), mineral contamination (MINC), chemical contamination (CC), microbial influenced corrosion (MIC) and biofilm creation. MC, MINC, CC, MIC and biofilm can be eliminated or greatly reduced with the treatment methods in or on equipment including pipelines, storage tanks, supplying systems, cooling systems, and processing equipment.

IPC Classes  ?

• A61L 2/10 - Ultraviolet radiation
• B01J 19/12 - Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor employing electromagnetic waves
• C02F 1/467 - Treatment of water, waste water, or sewage by electrochemical methods by electrolysis by electrochemical disinfection

Abstract

A method, system, and apparatus for sterilization, decontamination, and antimicrobial therapeutic treatment, which may include a dispensing device to cover a person, plant, animal, surface, enclosure, room or other structure or area with an antimicrobial solution. Radiation sources may expose the antimicrobial agent to a certain wavelength of radiation. The combination of the solution and the radiation may create a synergistic reaction that causes an effect greater than the radiation or solution separately. The same reaction creates a residual anti microbial effect. A container, area or passageway including an dispensing device a solution so that a person, plant, animal or object is covered or saturated with an antimicrobial solution. Exposure to a certain wavelength of radiation creates a residual, synergistic reaction resulting in a "supercharged" antimicrobial agent that exhibits retained antimicrobial effects that exist longer than previously discovered due to the antimicrobial agent being exposed to the radiation together.

IPC Classes  ?

• A61L 2/00 - Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
• A61L 2/10 - Ultraviolet radiation
• A61N 5/06 - Radiation therapy using light

Abstract

Medical and veterinary applications of light to therapeutic compounds include a solution retainer adapted to retain a therapeutic solution against a tissue of a user; a fiber optic cable; a light source that connects with the fiber optic cable and provides a light of a predetermined wavelength to the fiber optic cable; and a light termination on the fiber optic cable that exposes the light to the therapeutic solution. A formulation includes an oxidizer; the therapeutic solution having an initial therapeutic effectiveness; and a light of a predetermined frequency that that undergoes a synergistic reaction with the oxidizer, thereby enhancing the initial therapeutic effectiveness of the solution.

IPC Classes  ?

• A61N 5/06 - Radiation therapy using light
• A61C 19/06 - Implements for therapeutic treatment
• A61D 99/00 - Subject matter not provided for in other groups of this subclass
• A61H 99/00 - Subject matter not provided for in other groups of this subclass
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61P 35/00 - Antineoplastic agents

Abstract

Medical and veterinary applications of light to therapeutic compounds include a solution retainer adapted to retain a therapeutic solution against a tissue of a user; a fiber optic cable; a light source that connects with the fiber optic cable and provides a light of a predetermined wavelength to the fiber optic cable; and a light termination on the fiber optic cable that exposes the light to the therapeutic solution. A formulation includes an oxidizer; the therapeutic solution having an initial therapeutic effectiveness; and a light of a predetermined frequency that that undergoes a synergistic reaction with the oxidizer, thereby enhancing the initial therapeutic effectiveness of the solution.

IPC Classes  ?

• A61K 41/00 - Medicinal preparations obtained by treating materials with wave energy or particle radiation
• A61K 9/08 - Solutions
• A61P 31/04 - Antibacterial agents
• A61P 31/12 - Antivirals
• A61P 35/00 - Antineoplastic agents